Earn points on every order New products in stock Free 51-page beginner’s guide
← Back to Compound Library

GLUTATHIONE

Your body’s master antioxidant. Injected for liver support, brighter skin, and bouncing back from oxidative stress. Mix it fresh, it breaks down fast.

Research referenceCommunity compiled

Molecular profile

The molecule itself: sequence, composition, mass, target, and registry identifiers.

Molecular formula
C₁₀H₁₇N₃O₆S
Average mass
307.33 Da
CAS number
70-18-8
Registry
PubChem CID 124886
Receptor / pathway
Redoxantioxidant
Formula, mass and identifiers from PubChem CID 124886.
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Glutathione is the human body's master intracellular antioxidant, composed of three amino acids: glutamine, cysteine, and glycine.

What problem it targets: It targets high oxidative stress, heavy liver toxin burdens, cellular toxicity, dull or hyperpigmented skin, sluggish mitochondrial function, and chronic inflammation.

What It Does

• Neutralizes free radicals and reactive oxygen species: Directly quenches damaging oxidative molecules, protecting DNA, cell membranes, and proteins from cellular degradation.

• Powers Phase II liver detoxification: Conjugates with fat-soluble toxins, heavy metals, and medication byproducts, transforming them into water-soluble forms for safe excretion.

• Modulates skin pigmentation (melanin): Switches melanin synthesis from darker eumelanin to lighter pheomelanin, producing a brighter, more even skin complexion over time.

• Realistic expectations: Because oral glutathione is largely degraded in the gut, injectable (SubQ/IM/IV) delivery ensures full systemic bioavailability. Expect improved energy and clearer skin within 3 to 6 weeks.

Reconstitution

Vial sizeBAC water / SolventConcentration
600 mg+ 1.2 mL500 mg/mL
1500 mg+ 3 mL500 mg/mL

Protocol

PhaseFrequencyDoseNotes
Weeks 1–2Mon–Fri upper glute100Tolerance check at 100 mg. 5×/week = 500 mg/week. Watch for garlic taste, flushing, or injection-site sting. mg
Weeks 3–8Mon/Wed/Fri upper200Working dose ceiling (PeptideDosages canonical). 3×/week = 600 mg/week. Matches Empower/AgelessRx clinic 200
glutemgmg dose. Hold at 100 mg if 200 mg poorly tolerated.
Maintenance1–2×/week200Ongoing antioxidant support. Drop to once-weekly after the 8-week loading + working phase if benefit holds. mg
Off2–4 weeks–Essential break. Skipping leads to tolerance and diminishing returns. Cycle: 4 weeks on / 4 weeks off. Max: 12 weeks on / 4–8 weeks off. Hepatic methylation cycling supports best results with breaks. Timing: Daily SubQ, reconstitute fresh; oxidizes within hours. By sex: Unisex antioxidant, same protocol for men and women, no cycle effect. Confirm with a prescriber in pregnancy.

Handling & Stacking

Injection site
Upper outer glute preferred. Abdomen acceptable.
Storage
  • Freeze-dried: -4°F (stable long-term).
  • Reconstituted: use fresh, do not store for weeks.
  • Glutathione oxidizes to GSSG within hours at room temperature or once exposed to air/light; kept cold (36–46°F) and dark in the sealed amber vial it lasts only a few days.
  • Discard the moment it yellows (that’s oxidation).
  • Never room temperature; never freeze (ice crystals denature the tripeptide).
Side effects
Upper glute sting (brief). Flushing or garlic taste within 30 min. Reconstitute fresh only.
What to expect
  • Energy improvement and reduced oxidative fatigue within 2–4 weeks.
  • Skin brightening reported by many users.
  • Must reconstitute fresh, oxidises within hours of reconstitution.
  • Supply math 600mg → 8 vials | 1500mg → 4 vials (8-wk @ 200 mg × 3/wk) Fresh-dose note: a reconstituted vial covers ~3 doses but would sit refrigerated across the week, if you want each dose truly fresh, reconstitute a smaller vial (or add less BAC water for fewer doses) more often rather than holding one vial for several days.
Pairs well with
NAD+ (cellular redox stack); GHK-Cu (additive antioxidant); Vitamin C (recycle glutathione); BPC-157 (gut + systemic recovery); MOTS-c (mitochondrial)
Avoid
Sulfa allergy (theoretical). Concurrent chemotherapy (may interfere, physician supervision)

Safety & Patient Education

Contraindications
Sulfa allergy (theoretical, reaction-prone individuals), concurrent chemotherapy without oncology supervision
Warnings
Must be reconstituted fresh; oxidizes within hours. FDA has flagged compounded IV glutathione for skin-lightening use as an unproven indication with serious adverse event reports.
Drug interactions
Chemotherapy (cisplatin, doxorubicin, cyclophosphamide and others): glutathione may reduce both toxicity AND efficacy; do NOT combine outside an oncologist-supervised protocol Acetaminophen overdose treatment (N-acetylcysteine pathway): glutathione is the protected metabolite, supplemental IV/SubQ glutathione may augment NAC therapy but is not a substitute Warfarin: theoretical mild potentiation via reduced oxidative stress on coagulation factors; monitor INR if combining chronically Sulfa drugs (sulfonamide antibiotics, sulfasalazine, some diuretics): increased reaction risk in sulfa-allergic patients given the sulfhydryl group Methylating agents and SAMe: complementary methylation/redox support; theoretical synergy, no human interaction data
Labs
  • Compound-specific: CBC baseline; liver enzymes (AST/ALT, bilirubin) and renal function (BUN/creatinine, eGFR) at baseline and periodically through any repeated IV course, especially above ~5 g/dose (documented hepatotoxicity signal), Out of range?
  • Rising ALT/AST or bilirubin = hepatic stress from high-dose glutathione → cut the dose or space out the infusions; a falling eGFR = renal strain → hold and hydrate.
Stop criteria
Rash, hives, or sulfhydryl-type allergic reaction; severe injection-site irritation
Patient education
  • Reconstitute immediately before use; discard unused, glutathione oxidizes within hours and is no longer active.
  • Do not use during active cancer treatment without oncology coordination.
  • Skin-lightening use is unproven and the FDA has issued safety warnings about compounded IV products marketed for that purpose.
References
researchdosing · peptidedosages · DailyMed · PubMed